Ask AI

First to See, First to Act: Empowering NPs and PAs With Frontline Strategies to Recognize and Treat ATTR-CM

Learn how to identify the signs and symptoms of transthyretin amyloid cardiomyopathy (ATTR-CM) to facilitate timely diagnosis and treatment with disease-modifying therapies and develop individualized, evidence-based treatment plans for patients with ATTR-CM, through an expert-written ClinicalThought, downloadable slides, and on-demand webcasts.

Share

Program Content

Events

  • Live Event
    2025 Cardiology Intensive for Advanced Practice Providers-First to See, First to Act: Empowering NPs and PAs With Frontline Strategies to Recognize and Treat ATTR-CM
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

ATTR CM frontline strategies
First to See, First to Act: Empowering NPs and PAs With Frontline Strategies to Recognize and Treat ATTR-CM
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2025

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (Partners) in partnership with the the Academy of Physician Associates in Cardiology (APAC).

Supporters

This activity is supported by an educational grant from Alnylam Pharmaceuticals.

Alnylam Pharmaceuticals

Partners

Academy of Physician Associates in Cardiology (APAC)

ProCE Banner